Medivir AB is rated 3 out of 5 in the category pharmaceuticals. Read and write reviews about Medivir AB. Medivir is a research-based pharmaceutical company with a focus on oncology. We endeavour to develop innovative pharmaceuticals that meet substantial unmet medical needs. Our R&D portfolio is based on our established and proven technology platform. The pharmaceutical development work is conducted both in-house and through partnerships, usually with global pharmaceutical companies. Medivir is listed on the Nasdaq Stockholm Mid Cap List.
Company size
51-200 employees